BR112012030659A8 - Parvovírus vivo atenuado, vacina, e, métodos para a fabricação de uma vacina, e para a preparação de um parvovírus mutante - Google Patents
Parvovírus vivo atenuado, vacina, e, métodos para a fabricação de uma vacina, e para a preparação de um parvovírus mutanteInfo
- Publication number
- BR112012030659A8 BR112012030659A8 BR112012030659A BR112012030659A BR112012030659A8 BR 112012030659 A8 BR112012030659 A8 BR 112012030659A8 BR 112012030659 A BR112012030659 A BR 112012030659A BR 112012030659 A BR112012030659 A BR 112012030659A BR 112012030659 A8 BR112012030659 A8 BR 112012030659A8
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- parvovirus
- methods
- live attenuated
- preparing
- Prior art date
Links
- 241000125945 Protoparvovirus Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14341—Use of virus, viral particle or viral elements as a vector
- C12N2750/14343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14361—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122021023230A BR122021023230B8 (pt) | 2010-07-16 | 2011-07-18 | Vacina de combinação que compreende uma vacina compreendendo um parvovírus vivo atenuado |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10169872 | 2010-07-16 | ||
EP10169872.8 | 2010-07-16 | ||
US36568410P | 2010-07-19 | 2010-07-19 | |
US61/365,684 | 2010-07-19 | ||
PCT/EP2011/062203 WO2012007589A1 (en) | 2010-07-16 | 2011-07-18 | Live attenuated parvovirus |
Publications (4)
Publication Number | Publication Date |
---|---|
BR112012030659A2 BR112012030659A2 (pt) | 2017-01-24 |
BR112012030659A8 true BR112012030659A8 (pt) | 2021-09-28 |
BR112012030659B1 BR112012030659B1 (pt) | 2021-12-21 |
BR112012030659B8 BR112012030659B8 (pt) | 2022-10-04 |
Family
ID=42629432
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122021023230A BR122021023230B8 (pt) | 2010-07-16 | 2011-07-18 | Vacina de combinação que compreende uma vacina compreendendo um parvovírus vivo atenuado |
BR112012030659A BR112012030659B8 (pt) | 2010-07-16 | 2011-07-18 | Parvovírus vivo atenuado, vacinas que o compreendem e método para a fabricação das referidas vacinas |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122021023230A BR122021023230B8 (pt) | 2010-07-16 | 2011-07-18 | Vacina de combinação que compreende uma vacina compreendendo um parvovírus vivo atenuado |
Country Status (12)
Country | Link |
---|---|
US (1) | US9186398B2 (pt) |
EP (2) | EP3199178B1 (pt) |
JP (2) | JP6061850B2 (pt) |
CN (2) | CN102985108A (pt) |
BR (2) | BR122021023230B8 (pt) |
CA (1) | CA2802283C (pt) |
DK (2) | DK2593136T3 (pt) |
ES (1) | ES2623149T3 (pt) |
FR (1) | FR21C1022I2 (pt) |
NL (1) | NL301108I2 (pt) |
PT (1) | PT2593136T (pt) |
WO (1) | WO2012007589A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102985108A (zh) * | 2010-07-16 | 2013-03-20 | 英特维特国际股份有限公司 | 活的减毒的细小病毒 |
US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
WO2014080676A1 (ja) * | 2012-11-22 | 2014-05-30 | 旭化成メディカル株式会社 | 高感染価のパルボウイルスの生産方法 |
CA2892221A1 (en) * | 2012-12-19 | 2014-06-26 | Intervet International B.V. | Canine parvovirus type 2c isolates and methods of use |
AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
JP6414409B2 (ja) * | 2014-07-29 | 2018-10-31 | 株式会社微生物化学研究所 | 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン |
CN109735505A (zh) * | 2018-12-26 | 2019-05-10 | 河南农业大学 | 一株犬细小病毒毒株及其基因序列的扩增和应用 |
CN110845582B (zh) * | 2019-12-23 | 2021-07-23 | 杭州贤至生物科技有限公司 | 一种猫细小病毒重组蛋白及其单克隆抗体的制备 |
EP4240836A1 (en) | 2020-11-04 | 2023-09-13 | Intervet International B.V. | Canine parvovirus |
CN114426956B (zh) * | 2022-02-08 | 2023-11-17 | 辽宁益康生物股份有限公司 | 猫狂犬病泛白细胞减少症鼻气管炎鼻结膜炎四联灭活疫苗 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814510A (en) * | 1994-11-08 | 1998-09-29 | Cornell Research Foundation, Inc. | Attenuated canine parvovirus vaccine |
US5885585A (en) * | 1994-11-08 | 1999-03-23 | Cornell Research Foundation, Inc. | Attenuated canine parvovirus vaccine |
EP2012122A1 (en) * | 2007-07-06 | 2009-01-07 | Medigene AG | Mutated parvovirus structural proteins as vaccines |
EP2158211B1 (en) * | 2007-05-31 | 2016-08-10 | Medigene AG | Mutated structural protein of a parvovirus |
NZ599585A (en) | 2007-06-14 | 2013-12-20 | Univ Oklahoma State | Vaccines containing canine parvovirus genetic variants |
CN102985108A (zh) * | 2010-07-16 | 2013-03-20 | 英特维特国际股份有限公司 | 活的减毒的细小病毒 |
-
2011
- 2011-07-18 CN CN201180034991XA patent/CN102985108A/zh active Pending
- 2011-07-18 PT PT117324806T patent/PT2593136T/pt unknown
- 2011-07-18 DK DK11732480.6T patent/DK2593136T3/en active
- 2011-07-18 JP JP2013519115A patent/JP6061850B2/ja active Active
- 2011-07-18 DK DK17156212.7T patent/DK3199178T3/da active
- 2011-07-18 CN CN201710646762.2A patent/CN107254451B/zh active Active
- 2011-07-18 CA CA2802283A patent/CA2802283C/en active Active
- 2011-07-18 BR BR122021023230A patent/BR122021023230B8/pt active IP Right Grant
- 2011-07-18 US US13/810,349 patent/US9186398B2/en active Active
- 2011-07-18 WO PCT/EP2011/062203 patent/WO2012007589A1/en active Application Filing
- 2011-07-18 EP EP17156212.7A patent/EP3199178B1/en active Active
- 2011-07-18 EP EP11732480.6A patent/EP2593136B1/en active Active
- 2011-07-18 ES ES11732480.6T patent/ES2623149T3/es active Active
- 2011-07-18 BR BR112012030659A patent/BR112012030659B8/pt active IP Right Grant
-
2016
- 2016-07-27 JP JP2016147811A patent/JP6298499B2/ja active Active
-
2021
- 2021-06-04 NL NL301108C patent/NL301108I2/nl unknown
- 2021-06-08 FR FR21C1022C patent/FR21C1022I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
BR122021023230B1 (pt) | 2023-01-17 |
BR112012030659B1 (pt) | 2021-12-21 |
CN107254451A (zh) | 2017-10-17 |
CA2802283A1 (en) | 2012-01-19 |
US20130195913A1 (en) | 2013-08-01 |
ES2623149T3 (es) | 2017-07-10 |
EP3199178B1 (en) | 2020-02-19 |
JP6298499B2 (ja) | 2018-03-20 |
NL301108I2 (nl) | 2024-01-29 |
JP6061850B2 (ja) | 2017-01-25 |
JP2017029140A (ja) | 2017-02-09 |
BR112012030659A2 (pt) | 2017-01-24 |
JP2013535188A (ja) | 2013-09-12 |
CN102985108A (zh) | 2013-03-20 |
BR112012030659B8 (pt) | 2022-10-04 |
US9186398B2 (en) | 2015-11-17 |
EP2593136A1 (en) | 2013-05-22 |
BR122021023230B8 (pt) | 2023-12-12 |
CN107254451B (zh) | 2021-12-10 |
DK3199178T3 (da) | 2020-04-14 |
EP2593136B1 (en) | 2017-03-08 |
FR21C1022I1 (fr) | 2021-07-16 |
FR21C1022I2 (fr) | 2024-03-29 |
EP3199178A1 (en) | 2017-08-02 |
WO2012007589A1 (en) | 2012-01-19 |
PT2593136T (pt) | 2017-05-03 |
DK2593136T3 (en) | 2017-05-08 |
CA2802283C (en) | 2018-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012030659A8 (pt) | Parvovírus vivo atenuado, vacina, e, métodos para a fabricação de uma vacina, e para a preparação de um parvovírus mutante | |
IL229284A0 (en) | Assemblies of matrix material, non-cellular, extracellular, sterile, and methods for their production | |
EA201291157A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
PH12015501406B1 (en) | Preparation of poly alpha-1,3-glucan ethers | |
UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
MX359769B (es) | Metodos para descelularizar huesos. | |
IT1398927B1 (it) | Espressione batterica di un gene artificiale per la produzione di crm197 e derivati. | |
IT1398317B1 (it) | Nuovo procedimento per la preparazione del dronedarone. | |
IT1400545B1 (it) | Procedimento per la preparazione di tessuto biologico per protesi biologiche. | |
BR112013019613A2 (pt) | via aérea artificial melhorada. | |
IT1403244B1 (it) | Procedimento per la produzione di lipidi da biomassa. | |
UY34349A (es) | OCTAHIDROPIRROLO[1,2-a]PIRAZINA SULFONAMIDAS SUSTITUIDAS COMO BLOQUEADORES DE CANALES DE CALCIO | |
BR112013016679A2 (pt) | formulações de vitamina e em pó aperfeiçoadas | |
ITPI20110022A1 (it) | Filato elasticizzato, tessuto elasticizzato prodotto con detto filato elasticizzato e metodo per la produzione di detto filato | |
ITTO20110857A1 (it) | Procedimento per la produzione di cicloesanonossina. | |
CO6771436A2 (es) | Método de preparación de nueva medicina antibacterialde polipéptido recombinante | |
TR201007106A1 (tr) | Sefpodoksim proksetil formülasyonları. | |
TR201002878A2 (tr) | Sefpodoksim proksetil içeren farmasötik bileşimler. | |
BR112013010541A2 (pt) | método de preparação de 1,3,5-trioxano | |
BR112015021772A2 (pt) | método para a preparação de células embrionárias aviárias, método melhorado para a preparação de células embrionárias aviárias a partir de um embrião, cultura ou composição de células embrionárias aviárias, método para a produção ou amplificação de um vírus, e, composição de vacina | |
IT1403147B1 (it) | Procedimento per la produzione di pietre artificiali | |
CL2011002741S1 (es) | Reposera. | |
IT1403678B1 (it) | Filamento per erba artificiale. | |
EA201400188A1 (ru) | Способ получения кристаллической формы i агомелатина | |
IT1397834B1 (it) | Torcitoio per la realizzazione di erba artificiale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/07/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2659 DE 21/12/2021 QUANTO AO QUADRO REIVINDICATORIO. |